Stocks Health care COCH
NASDAQ · Health careEnvoy Medical, Inc. (COCH)
Envoy Medical, Inc. brought in $207K of revenue over the twelve months to June 30, 2026, down 6.8% from a year earlier. It posted a net loss of $23.4M. In fiscal 2025 capital spending exceeded operating cash flow by $18.4M. At June 30, 2026 it held $19.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Envoy Medical, Inc. does
Envoy Medical, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker COCH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $241K | -$23.8M | -$1.23 | -$18.4M |
| 2024 | $225K | -$20.8M | -$1.49 | -$18.9M |
| 2023 | $316K | -$29.9M | -$2.54 | -$17.2M |
| 2022 | $237K | -$15.9M | -$1.68 | -$9M |
| 2021 | n/a | -$251.6K | n/a | n/a |
Latest SEC filings
What Envoy Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026Passive stake changed SCHEDULE 13G/A
- September 2, 2026Additional proxy material DEFA14A
- August 31, 2026Proxy statement DEF 14A
- August 27, 2026
- August 19, 2026Preliminary proxy statement PRE 14A
- August 10, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- June 30, 2026
- June 25, 2026
- June 12, 2026Form POS AM filing POS AM
Questions about COCH
What does Envoy Medical, Inc. do?
Envoy Medical, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker COCH.
Is Envoy Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $23.4M on revenue of $207K.
How much revenue does Envoy Medical, Inc. make?
Over the twelve months to June 30, 2026 Envoy Medical, Inc. reported revenue of $207K. That is 6.8% less than a year earlier.
When did Envoy Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from September 14, 2026.
Similar companies
Follow COCH
Get an email when Envoy Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow COCH: get an email when it filesWhere the numbers come from
Financial figures are the values Envoy Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.